glp-1 in psych patients GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements quality of life, emotional eating, and mental well-being. https://ja.ma/4l4f4Kl GLP-1 Medications in Psychiatry: Evidence-Based

Since GLP-1 RAs have only recently become more ubiquitously used, researchers are still trying to understand how they affect eating habits

The active compound is either semaglutide or tirzepatide, depending on what your provider prescribes

A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models

This property makes it valuable as a natural stabilizing agent, contributing to desired rheological characteristics and extending shelf life

I would rather pay a little more for a vial with a certificate of analysis I can read than save a few dollars on something anonymous